◆英語タイトル：Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4447
◆発行会社（調査会社）：
MarketLine
◆発行日：2018年8月
◆ページ数：43
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
MarketLine社の概要はこちらでご確認いただけます。
Sanofi Genzyme – Strategy, SWOT and Corporate Finance Report
Summary
Sanofi Genzyme – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Sanofi Genzyme (Genzyme), a specialty care global business unit of Sanofi provides treatments with a focus on rare diseases, multiple sclerosis, immunology, and oncology. The major products of the company include Aldurazyme, Aubagio, Caprelsa tablets, Cerdelga capsules, Cerezyme, Clolar, Dupixent injection, Elitek, Eloxatin, Fabrazyme, Jevtana, Kevzara injection, Lemtrada, Lumizyme, Mozobil injection, Taxotere injection concentrate, Thymoglobulin, Thyrogen and ZALTRAP injection for intravenous infusion. The company also addresses the unmet needs in immune diseases including atopic dermatitis, rheumatoid arthritis, asthma, nasal polyposis, and eosinophilic esophagitis. The company primarily operates in the Americas and Europe. Genzyme is headquartered in Cambridge, Massachusetts, the US.
Scope
- Detailed information on Sanofi Genzyme required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanofi Genzyme in the form of a SWOT analysis
- An in-depth view of the business model of Sanofi Genzyme including a breakdown and examination of key business segments
- Intelligence on Sanofi Genzyme’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanofi Genzyme, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Sanofi Genzyme and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sanofi Genzyme as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sanofi Genzyme’s business structure, strategy and prospects.
Table of Contents
Company Snapshot 2
Table of Contents 5
Sanofi Genzyme: Company Overview 9
Sanofi Genzyme: Overview and Key Facts 9
Sanofi Genzyme: Overview 9
Sanofi Genzyme: Key Facts 9
Sanofi Genzyme: Key Employees 10
Sanofi Genzyme: Key Employee Biographies 12
Sanofi Genzyme: Major Products and Services 14
Sanofi Genzyme: Company History 15
Sanofi Genzyme: Locations and Subsidiaries 21
Sanofi Genzyme: Key Competitors 22
Sanofi Genzyme: Company Analysis 23
Sanofi Genzyme: Business Description 23
Sanofi Genzyme: SWOT Analysis 25
Sanofi Genzyme: SWOT Overview 25
Sanofi Genzyme: Strengths 25
Sanofi Genzyme: Weaknesses 26
Sanofi Genzyme: Opportunities 26
Sanofi Genzyme: Threats 27
Sanofi Genzyme: Corporate Financial Deals Activity 28
Sanofi Genzyme: Financial Deals Overview 28
Sanofi Genzyme: Targets and Partners 29
Sanofi Genzyme: Top Deals 2014 – 2018YTD* 30
Sanofi Genzyme: Mergers and Acquisitions 31
Sanofi Genzyme: Partnership 32
Sanofi Genzyme: Recent Developments 33
Sanofi Genzyme: News and Events Summary 33
Sanofi Genzyme: Contracts 36
Sanofi Genzyme: Market Developments 36
Sanofi Genzyme: Regulatory and Legal Events 38
Sanofi Genzyme: Research & Development 39
Sanofi Genzyme: Strategy and Operations 40
Appendix 41
Contact Us 41
Methodology 41
About MarketLine 42
List of Tables
Table 1: Sanofi Genzyme: Key Facts
Table 2: Sanofi Genzyme: Key Employees
Table 3: Sanofi Genzyme: Locations and Subsidiaries
Table 4: Sanofi Genzyme: Key Competitors
Table 5: Sanofi Genzyme: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Sanofi Genzyme: M&A Average Deal Size - Value (US$m)
Table 7: Sanofi Genzyme: Targets and Partners
Table 8: Sanofi Genzyme: Top Deals 2014 - 2018YTD*
Table 9: Sanofi Genzyme: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Sanofi Genzyme: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 11: Sanofi Genzyme: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 12: Sanofi Genzyme: News and Events Summary
Table 13: Sanofi Genzyme: Contracts
Table 14: Sanofi Genzyme: Market Developments
Table 15: Sanofi Genzyme: Regulatory and Legal Events
Table 16: Sanofi Genzyme: Research & Development
Table 17: Sanofi Genzyme: Strategy and Operations
List of Figures
Figure 1: Sanofi Genzyme: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Sanofi Genzyme: M&A Average Deal Size - Value (US$m)
Figure 3: Sanofi Genzyme: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Sanofi Genzyme: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 5: Sanofi Genzyme: Partnership Trend by Deal Type (2014 - YTD*2018)
